Literature DB >> 6957647

Collagen polymorphism in extracellular matrix of human osteosarcoma.

F D Shapiro, D R Eyre.   

Abstract

The collagenous matrix of human osteosarcoma was characterized biochemically and ultrastructurally. The highly cellular regions of the tumors contained many osteoblast-like cells filled with dilated rough endoplasmic reticulum. The extracellular matrix displayed a random weave of banded collagen fibrils (30--90 nm in diameter) interspersed with thinner, unbanded fibrils (15 nm in diameter). Tumors from 9 patients were analyzed for collagen composition. All gave a similar collagen profile. Three main molecular species of collagen were abundant: type I, type III, and type V, which occurred in the approximate proportions of 65:25:10. A high ratio of alpha 1(I) to alpha 2(I) chains suggested that one-third of the type I collagen was present as a type I trimer molecule. In contrast, normal bone matrix consisted almost exclusively of type I collagen. The fibrillar collagens in the soft tumor seemed unusually rich in hydroxylysine and hydroxylysine glycosides; type I collagen had two to three times the hydroxylysine content of normal bone collagen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6957647

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  14 in total

1.  Conformational dynamics accompanying the proteolytic degradation of trimeric collagen I by collagenases.

Authors:  Arjun S Adhikari; Emerson Glassey; Alexander R Dunn
Journal:  J Am Chem Soc       Date:  2012-08-01       Impact factor: 15.419

2.  Synthesis of type I homotrimer collagen molecules by cultured human lung adenocarcinoma cells.

Authors:  J H Rupard; S J Dimari; I Damjanov; M A Haralson
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

3.  The interface between catalytic and hemopexin domains in matrix metalloproteinase-1 conceals a collagen binding exosite.

Authors:  Laurence H Arnold; Louise E Butt; Stephen H Prior; Christopher M Read; Gregg B Fields; Andrew R Pickford
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

4.  Type I collagen formation in rat type II alveolar cells immortalised by viral gene products.

Authors:  R Matsui; R H Goldstein; K Mihal; J S Brody; M P Steele; A Fine
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

5.  Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion.

Authors:  Elena Makareeva; Sejin Han; Juan Carlos Vera; Dan L Sackett; Kenn Holmbeck; Charlotte L Phillips; Robert Visse; Hideaki Nagase; Sergey Leikin
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

6.  The post-translational phenotype of collagen synthesized by SAOS-2 osteosarcoma cells.

Authors:  Russell J Fernandes; Michael A Harkey; Maryann Weis; Jennifer W Askew; David R Eyre
Journal:  Bone       Date:  2007-01-25       Impact factor: 4.398

7.  Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases.

Authors:  Sejin Han; Elena Makareeva; Natalia V Kuznetsova; Angela M DeRidder; Mary Beth Sutter; Wolfgang Losert; Charlotte L Phillips; Robert Visse; Hideaki Nagase; Sergey Leikin
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

Review 8.  Hypoxia and the extracellular matrix: drivers of tumour metastasis.

Authors:  Daniele M Gilkes; Gregg L Semenza; Denis Wirtz
Journal:  Nat Rev Cancer       Date:  2014-05-15       Impact factor: 60.716

9.  Composition and posttranslational modification of individual collagen chains from osteosarcomas and osteofibrous dysplasias.

Authors:  H W Lehmann; E Wolf; K Röser; M Bodo; G Delling; P K Müller
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  In vivo quantification of the structural changes of collagens in a melanoma microenvironment with second and third harmonic generation microscopy.

Authors:  Pei-Chun Wu; Tsung-Yuan Hsieh; Zen-Uong Tsai; Tzu-Ming Liu
Journal:  Sci Rep       Date:  2015-03-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.